Open AccessCerebral and splenic infarctions after injection ofN-butyl-2-cyanoacrylate in esophageal variceal bleeding
Author(s) -
DaeSeong Myung,
Chul Chung,
HyungChul Park,
Jong-Sun Kim,
Sung-Bum Cho,
WanSik Lee,
SungKyu Choi,
YoungEun Joo
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i34.5759
Subject(s) - cyanoacrylate , medicine , sclerotherapy , ligation , embolization , surgery , complication , portal hypertension , cirrhosis , esophageal varices , splenectomy , gastric varices , varix , gastroenterology , spleen , chemistry , adhesive , organic chemistry , layer (electronics)
Variceal bleeding is the most serious complication of portal hypertension, and it accounts for approximately one fifth to one third of all deaths in liver cirrhosis patients. Currently, endoscopic treatment remains the predominant method for the prevention and treatment of variceal bleeding. Endoscopic treatments include band ligation and injection sclerotherapy. Injection sclerotherapy with N-butyl-2-cyanoacrylate has been successfully used to treat variceal bleeding. Although injection sclerotherapy with N-butyl-2-cyanoacrylate provides effective treatment for variceal bleeding, injection of N-butyl-2-cyanoacrylate is associated with a variety of complications, including systemic embolization. Herein, we report a case of cerebral and splenic infarctions after the injection of N-butyl-2-cyanoacrylate to treat esophageal variceal bleeding.